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Introduction
The terms “p value” and “significance” are probably the
most used statistical concepts in science literature [1].
In the field of epidemiology, the key role of signifi-
cance is clearly visible in all kinds of epidemiological
studies: experimental (comparison between two drugs
in a clinical trial), analytic (case control or cohort stud-
ies designed to analyse health effects of a specific ex-
posure), and descriptive (distribution of a disease by
age, sex, or geographic location). Finding out if an as-
sociation is real or due to chance, relevant or not,
caused by confounders or influenced by interactions, is
the common task for all these types of research, while
correctly interpreting the p value is the shared problem.
A series of articles recently published confirmed our
personal experience emphasizing significance interpre-
tation as a topical point in epidemiology [2-7]. As
states Smith “the debate about the appropriate place of
p values in scientific inference is still alive” [2].
Specifically, the controversy about the correct interpre-
tation of p value has arisen since this parameter was
proposed in 1925, and there is still strong disagreement
and confusion about this [8].
This paper aims to discuss the main issues related to
significance. The article is structured as a glossary; it is
not merely descriptive, including not only “technical
terms” (power, type I error, confidence interval), but al-
so a number of “interpretative terms” in order to illus-
trate the debate about significance since its origin, in-
cluding our personal view.
This glossary is intended mainly for health profession-
als, who have to deal with significance, in order to iden-
tify relevant health determinants, to develop health pro-
motion programmes, risk assessment, to realize risk
communication programs, to plan vaccination cam-
paigns, and to evaluate the effectiveness of their actions.
Statistical Inference
There is no complete consensus in the definition of the
main function of statistical inference. Inference literal-
ly means the process of forming an opinion based on
what you already know.
Statistical inference is the process of drawing conclu-
sions about a population, based on the analysis of a
sample. “By means of statistical inference it is possible
to draw conclusions about models which potentially
may have generated the data, and to apply the results to
the entire population” [9]. The generalisation of the re-
sults from the sample to the population is burdened by
some level of uncertainty. According to some Authors
the objective measurement of this uncertainty, and so
the p value is one of the main goals of statistical infer-
ence [9]. Other Authors emphasize the primary func-
tion of statistics in providing clear and precise descrip-
tion, and consider the calculation of p value as the least
important role of a statistical inference [10].
Frequentist School of Inference
The Frequentist School methodology is based on the as-
sumption that an experiment is repeated an infinite num-
ber of times. The evaluation of the inferential process
should be made using these virtual repetitions of experi-
ments [9]. In other words it has been demonstrated that
if all possible samples from a population were selected,
and the data analysis was repeated for each sample, most
samples would give similar results (common value), but
some, just by chance, would give very different results
(rare value). So, according to the frequentist school, the
result from one sample has to be compared to the other
potential results indicating how rare it is.
Critics state that inference must be based only on re-
sults from real experiments, and consequently using
methods based on virtual results is incorrect [9].
In spite of this widespread criticism the frequentist
school is the most used method of inference, especial-
ly the techniques of Hypothesis testing and Confidence
Interval [9, 11].
Hypothesis Testing
The procedure of hypothesis testing assesses the uncer-
tainty linked to a parameter calculated from a sample,
verifying a null and an alternative hypothesis [12].
The null hypothesis is the statement that no difference
exists between groups, or that there is no association
between a determinant and an outcome. If the null hy-
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pothesis is true then the difference (or association) seen
in a study results from chance [13, 14].
The alternative hypothesis is in contradiction to the
null hypothesis, stating that some difference between
groups exists, or that there is some association between
a determinant and an outcome [15].
The hypothesis testing procedure evaluates, by means
of statistical tests, if the observed data are more consis-
tent with the null or the alternative hypothesis, calcu-
lating how likely the observed difference or association
could arise by chance; if this probability is low the null
hypothesis should be rejected.
Statistical tests
Statistical tests provide a systematic approach to decide
if the null hypothesis should be rejected or accepted,
and to assess uncertainty linked to this decision.
A test value is calculated from sample data with appro-
priate statistical procedures (according to the charac-
teristic of examined data).
A large test value indicates a departure from the null
hypothesis. To evaluate if the obtained test value is
large enough to reject the null hypothesis, it is assumed
that the calculation is repeated an infinite number of
times with different random samples drawn from the
same population. If the test value is larger than most of
the values obtained from the different random samples,
this could be uneasily attributed to chance, and so the
null hypothesis should be rejected.
This methodology does not address the issue of
whether an association is causal or not: the concept of
association refers to a dependence, which may or may
not be casual, between two or more variables [16, 17].
p-value
The methodology of p value was first proposed as part
of an inference method by Fisher in 1925, and later in
1933 it was introduced again in the context of hypoth-
esis testing by Neyman and Pearson [1].
The p value (short for probability value) is defined as
the probability of obtaining by chance, from the ob-
served data, the observed test value or a larger one. The
p value is considered as summarizing the statistical ev-
idence of an experiment, and it is interpreted as dis-
crediting the null hypothesis if p is small and in favour
of the null hypothesis if p is large [1].
The p value is influenced by both the magnitude of the
effect and the sample size, and if these factors are not
taken into account, two opposite consequences are pos-
sible [18].
On the one hand, if the selected sample is too large, the
experiment might result in a small p value even though
the magnitude of the effect is not relevant.
On the other hand if the sample is too small, the study
may not result in a small p value even if the magnitude
of the effect is really relevant.
Type I and Type II Error
When the procedure of hypothesis testing is performed,
the probability of making a wrong decision exists, and
two types of errors are possible [12]:
– type I (α error) that is the probability of rejecting
the null hypothesis when it is true; in a clinical con-
text it is the probability of “false positive”: that a
healthy person is erroneously considered sick;
– type II (β error) that is the probability of accepting
the null hypothesis when the alternative is true; in a
clinical context it is the probability of false “nega-
tive”: that a sick person is erroneously considered
healthy.
The concept of α error, or false positive, is linked to the
term specificity. The specificity is the ability of a clin-
ical test to correctly individualize the absence of a dis-
ease when it is really absent, consequently when a test
is not specific it also indicates the disease in a healthy
subject.
In designing a study both types of error should ideally
be minimized [19]. Nevertheless researchers usually
pay more attention to type I error than to type II, with-
out considering that the decrease in the probability of α
error is often achieved with an increase in the probabil-
ity of β error [19].
Level of a Test
The probability of making a type I error is called the
level of a test or the level of significance [20]. In other
words the level of a test is the probability of rejecting
the null hypothesis when in fact it is true. According to
the original approach of hypothesis testing proposed by
Neyman-Pearson a researcher should decide in advance
the level of α [12]. Then he should select and perform
the appropriate statistical test. The decision to reject or
accept the null hypothesis should be based on the com-
parison between the test procedure’s p value and the
previously chosen level of the test.
“If the p value is less than the level of the test, then the
experimental data are considered to be inconsistent
with the null hypothesis, that is rejected, and the result
is declared to be significant at that particularly level. If
the p value is greater than the level of the test, then the
null hypothesis is accepted” [20].
Significance
The term significance literally means the importance of
something, and the adjective significant indicates that
something is important enough to have an effect or to
be noticed.
In statistical inference a result from an experiment in
which the null hypothesis is rejected is called signifi-
cant. In the context of hypothesis testing the concept of
statistical significance refers to whether or not the p
value of a statistical test exceeds the previously chosen
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test level [21]. When a researcher states that a result is
statistically significant, it means that it is probably true
and not due to chance. Nevertheless a difference or an
association may be true without being important: a sta-
tistically significant difference is not necessarly biolog-
ically or clinically important [19, 21]. On the contrary
a result that is not statistically significant could be im-
portant.
Consequently it can also be useful to consider the prac-
tical significance of a result, with reference to its real
importance.
Magnitude of Effect
When a significant result is obtained, not necessarily
the observed effect (difference or association) is rele-
vant for practice [22]. Consequently a researcher
should establish in advance how big a magnitude
should be to consider the effect important.
“The expected magnitude of an effect can be estimated
from previously published reports, or if unavailable,
may be taken to represent the minimum effect that the
investigators would consider meaningful” [19].
Sample Size
A sample is a selected subset of the target population,
that is also expected to represent non selected individ-
uals [23]. As a first step, the researcher should establish
how many subjects should be studied to detect a signif-
icant effect if it actually exists [19].
Sample size determination requires the researcher to
quantify the magnitude of the effect that is judged im-
portant to be detected, and the allowable magnitude of
α and β error [19, 22]. Then the sample size can be cal-
culated by means of simple mathematical calculations
chosen on the basis of the statistical test selected for the
analysis.
Sometimes in assembling an adequate sample size, ob-
jective limits exist such as the low disease rate in the
population of interest, logistic problems, or budgetary
constraints [19].
Power
The power is the ability of a study to detect an effect
(difference or association) if one exists.
The power of a study is influenced by the magnitude of
an effect, the sample size, the α and β error. Mathe-
matically, power is 1-β [19, 22, 24].
The concepts of power correspond to the term sensitiv-
ity that is the ability of a test to correctly identify a dis-
ease when it is really present; consequently when a test
is not sensitive it could indicate sick people as healthy
subjects.
Knowing the power of a specific study is a helpful ele-
ment in interpreting results. This is particularly true for
research in which the sample size has objective limita-
tions (for example a rare disease or a small population).
In fact if a study is made using an inadequate sample
size due to objective limits, non significant results
might be due both to a true lack of association and to
the impossibility of detecting the association because
of the low power. Practical consequences do not take
into account this important point, that non significant
but relevant results can be easily discarded.
Meta-analysis, aggregating data from single studies,
could help to cope with power problems and efficient-
ly furnish a statistical evidence [19].
Confounding & Interaction Effects on P-
value
“The term confounding refers to the effect of an extra-
neous variable that wholly or partially accounts for the
apparent effect of the study exposure, or that masks an
underlying true association” [16].
With reference to p value this means that when a sig-
nificant association between two variables is found,
this relationship could be modified by the insertion of
a third parameter in the analysis: the p value could be-
come smaller or larger, and the association could be-
come even non significant [25].
An interaction between two or more determinants ex-
ists at any time that the joint action of these determi-
nants produces an effect that is smaller or greater than
the mathematical combination (sum or product) of the
individual effects [26]. As far as the interaction’s sig-
nificance is concerned, it is important to highlight that
the level of significance should be higher than the usu-
al ones: according to Selvin 0.20 should be the consid-
ered level of the test, and a p value less or equal to 0.20
is an indicator for the interaction [26].
In planning a case control study one should regard any
known risk factor as a potential confounder and should
evaluate any possible interaction between these vari-
ables [16].
Confidence Interval
The method of confidence interval, proposed by Ney-
man and based on frequentist inference, is developed
from the assumption that a population parameter is
fixed, but unknown [27].
Through data analysis of a sample, it is possible to
make inference about the population from which the
sample was selected. Clearly the parameter calculated
for the sample (i.e. a mean) is not exactly equal to the
real value of the population parameter, but it is an esti-
mate of it [28].
A confidence interval for a sample parameter gives an
indication of the precision of the estimate showing the
range within which the real population parameter is
likely contained. Specifically, for a parameter it is pos-
sible to construct the lower and upper limits that re-
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spectively indicate how small or large the parameter
value might be in the population.
The wider the confidence interval is, the more uncer-
tain the parameter estimate is, and on the contrary the
narrower the interval the more certain the estimate.
The confidence interval, is calculated with a given
probability that the true value of the parameter is con-
tained within the interval. This probability is called the
confidence coefficient or confidence level, mathemati-
cally it is 1-α, and it is usually considered equal to 95%
(1-0.05). In other words there is a 95% chance that the
interval you calculate includes the true population pa-
rameters [27].
The sample size, the variability (dispersion) among da-
ta, and the confidence level influence the lenght of the
confidence interval.
A criticism of confidence intervals is that “no distinc-
tion is made as to whether the population parameter is
likely to have a higher probability of being in the
neighborhood of sample parameter compared with be-
ing at the ends of the interval” [9].
In accordance with Fisher “the value of the parameter is
more likely to be in a neighborhood of sample parame-
ter compared with being located in a neighborhood
around the boundary of the confidence interval” [9, 29].
Statistical inference could be made in a more proper
way using the confidence interval together with the p
value obtained by hypothesis testing. Through the si-
multaneous use of p value and confidence interval it is
possible to assess both statistical and to be oriented
about clinical significance.
In fact the p value gives the probability that a sample
parameter is obtained by chance: if p value is small the
result is statistically significant and probably not due to
chance. The confidence interval gives you the proba-
bility that the population parameter is big enough to
count for clinical or practical significance, giving the
smallest and the largest value that the population para-
meter can assume [29].
p-value according to Fisher
The p value was proposed for the first time by Fisher as
part of a method of inference in 1925.
According to Fisher’s original purpose the p value was
an index useful to measure if observed results are con-
sistent with a null hypothesis: the smaller the p value, the
greater the evidence against the null hypothesis [1]. If the
p value is between 0.1 and 0.9 there is certainly no rea-
son to reject the null hypothesis; if it is below 0.02 it is
strongly indicated that the null hypothesis fails to ac-
count for the whole of the facts [8]. Fisher disagreed with
the idea that p value was ultimately for the researcher: a
p value of about 0.05 should lead to another experiment,
not to accept or reject the null hypothesis [1, 8].
Without doubt, in Fisher’s approach, the p value has a
subjective and gradual interpretation. Clearly in this
approach, where the smaller the p value the greater is
the evidence against the null hypothesis, it is important
to specify the exact p value: a p value of about 0.001 is
stronger evidence than a p value of 0.01.
p-value according to Neyman-Pearson
In 1933 Neyman and Pearson proposed a methodology
called hypothesis testing, introducing the concepts of
alternative hypothesis, type I error, type II error, and
power [1].
According to this approach, in research involving a null
and an alternative hypothesis, the researcher should es-
tablish in advance the magnitude of the effect that is
relevant to point out, fix the level of type I error he can
accept, and calculate the sample size that at the same
time can minimize the type II error and detect the effect
if it exists [1, 8]. After the experiment the p value
should be calculated through a test of significance; if
the p value is smaller than the fixed α level, the null hy-
pothesis should be rejected, otherwise it should be ac-
cepted. In Neyman-Pearson’s theory not considering α
equal to 0.05 but establishing an appropriate α value in
advance, is the crucial point.
Thus, in the Neyman Pearson objective approach we
decide in advance the α level, and the result of the
analysis leads automatically to reject or accept the null
hypothesis.
In this metodology, “we make no attempt to interpret
the p value to assess the strenght of evidence against
the null hypothesis” [8].
For this reason it is important only knowing whether
the p value is lower or higher than the α level, and not
the exact p value: if α is equal to 0.10 there is no dif-
ference between a p value of 0.06 and a p value of 0.01
because both constitute the same evidence against the
null hypothesis.
Obviously the researcher is free to change α level, but
this must be done in advance of the statistical test [1, 8].
Heirs of Fisher or Heirs of Neyman-
Pearson?
The strong disagreement on p value interpretation has
its source exactly in the different methods proposed by
Fisher and Neyman Pearson. In fact in time the differ-
ences between the two original approaches have been
neglected, and the result is a considerable confusion
that has led to the widespread misunderstanding of the
nature of statistical significance [8].
In scientific literature, the current tendency is to reject
the null hypothesis when the p value is equal or less
than 0.05, otherwise to accept it, without regard to the
type the study and to other available evidence [8].
This approach is arbitrary because neither Fisher nor
Neyman-Pearson stated that 0.05 was to be the dis-
criminating value to accept or reject the null hypothe-
sis.
In our opinion the selection of the most suitable ap-
proach for a specific study (Fisher’s subjective or Ney-
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man Pearson’objective ones) should be the first step of
the statistical inference. The type of study should be a
key factor in this selection process; for example Fish-
er’s approach could be useful for analytic study aimed
at exploring the effects of the exposure on health, while
Neyman-Pearson approach could be useful for clinical
trials testing a new drug.
If Fisher’s approach is used, p value should only be on-
ly a guide to interpret results, and it should be evaluat-
ed in the light of several factors. The confidence inter-
val, the sample size, the power, the biological plausi-
bility, the evidence of dose response, and the consis-
tence of the evidence within and across studies should
be looked at carefully.
Analogously, when Neyman-Pearson’s approach is used,
the α level should not be equal to 0.05 by convention,
but should be fixed in advance of the statistical test in the
light of the same factors previously listed.
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